Sign up to save your podcasts
Or
Share When Hyperkalemia Impairs Optimal Treatment of HF and CKD: What New Guidelines Recommend
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
When Hyperkalemia Impairs Optimal Treatment of HF and CKD: What New Guidelines Recommend
Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF). Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996906?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF). Credit available for this activity expires: 9/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996906?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
NEJM This Week
321 Listeners
JAMA Clinical Reviews
497 Listeners
WSJ Tech News Briefing
1,642 Listeners
This Week in Cardiology
881 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
291 Listeners
The Curbsiders Internal Medicine Podcast
3,350 Listeners
The Peter Attia Drive
8,549 Listeners
Annals On Call Podcast
192 Listeners
JAMA Medical News
93 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
28 Listeners
Cardionerds: A Cardiology Podcast
426 Listeners
The Curious Clinicians
374 Listeners
Huberman Lab
29,220 Listeners
Not Otherwise Specified
65 Listeners